The search for markers and therapeutic targets for personalized treatment of oncological diseases showed that the product of the POU2F1 (Oct-1) gene is an extremely significant factor in the development and progression of many malignant tumors of both epithelial origin and tumors of the hematopoietic and lymphoid tissues [1]. The gene discussed is POU2F1; the disease is cancer.